Remedium Lifecare - Supha Pharmachem Share Price

Remedium Lifecare - Supha Pharmachem Share Price

  • 0.29-0.01 (-3.33%)
BSE
  • Closed
  • As On: 25 Jun, 2026, 03:37 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)2.24
EPS - TTM(₹)0.13
MCap(₹ Cr.)25.58
MCap Rank56
PB Ratio(x)0.60
Div Yield(%)-
Face Value(₹)1.00
52W High(₹)1.80
52W Low(₹)0.25
MCap/Sales0.18
Beta(1 Month)-
BV/Share(₹)0.50

Remedium Lifecare share price insights

We don’t have any Insights for this stock currently.

Remedium Lifecare Share Price Returns

1 Day-3.33%
1 MonthN.A.
3 Months-14.71%
1 Year-68.13%
3 Years-99.21%
5 Years-68.19%

Remedium Lifecare Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Sep 2025
    Total Income114.31
    Total Income Growth (%)-2.17
    Total Expenses103.69
    Total Expenses Growth (%)-7.00
    EBIT10.62
    EBIT Growth (%)98.67
    Profit after Tax (PAT)8.62
    PAT Growth (%)85.50
    EBIT Margin (%)9.29
    Net Profit Margin (%)7.54
    Basic EPS (₹)0.10
    Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
    Total Income11.8321.8582.2345.5825.90
    Total Income Growth (%)-45.86-73.4380.4075.96-67.45
    Total Expenses11.5722.5882.7643.6420.63
    Total Expenses Growth (%)-48.76-72.7189.64111.50-73.31
    EBIT0.26-0.73-0.531.945.27
    EBIT Growth (%)---127.12-63.14132.55
    Profit after Tax (PAT)0.07-0.37-2.640.761.78
    PAT Growth (%)---445.77-56.938.50
    EBIT Margin (%)2.21-3.34-0.644.2620.35
    Net Profit Margin (%)0.62-1.67-3.211.686.85
    Basic EPS (₹)0.000.00-0.070.020.04
    FY 2025
    Total Revenue416.05
    Total Revenue Growth (%)-
    Total Expenses411.67
    Total Expenses Growth (%)-
    Profit after Tax (PAT)2.13
    PAT Growth (%)-
    Operating Profit Margin (%)2.38
    Net Profit Margin (%)0.52
    Basic EPS (₹)0.05
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue233.304,062.79509.84504.7990.04
    Total Revenue Growth (%)-94.26696.881.00460.663,015.21
    Total Expenses229.644,012.33502.44503.2789.38
    Total Expenses Growth (%)-94.28698.57-0.16463.043,453.58
    Profit after Tax (PAT)1.5332.735.431.080.48
    PAT Growth (%)-95.32503.20403.44124.3173.47
    Operating Profit Margin (%)4.021.341.430.320.72
    Net Profit Margin (%)0.680.801.060.210.53
    Basic EPS (₹)0.043.2515.072.991.33

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2025
    Total Assets1,720.35
    Total Assets Growth (%)-
    Total Liabilities-
    Total Liabilities Growth (%)-
    Total Equity43.89
    Total Equity Growth (%)-
    Current Ratio (x)1.03
    Total Debt to Equity (x)26.01
    Contingent Liabilities-
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets1,539.651,947.921,154.22223.7638.53
    Total Assets Growth (%)-20.9668.77415.83480.74802.34
    Total Liabilities1,496.351,904.971,143.86218.8234.68
    Total Liabilities Growth (%)-21.4566.54422.74530.973,710.99
    Total Equity43.3042.9610.364.943.86
    Total Equity Growth (%)0.79314.67109.7227.9815.22
    Current Ratio (x)1.031.021.011.021.59
    Total Debt to Equity (x)26.361.340.000.002.72
    Contingent Liabilities-----

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2025
    Net Cash flow from Operating Activities-1,134.81
    Net Cash used in Investing Activities0.13
    Net Cash flow from Financing Activities1,136.10
    Net Cash Flow1.43
    Closing Cash & Cash Equivalent1.43
    Closing Cash & Cash Equivalent Growth (%)-
    Total Debt/ CFO (x)-1.01
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities--74.1620.5011.28-10.21
    Net Cash used in Investing Activities---0.04-0.05-0.04
    Net Cash flow from Financing Activities-53.83-0.04-10.6110.14
    Net Cash Flow--20.3320.420.62-0.11
    Closing Cash & Cash Equivalent-1.5221.861.440.81
    Closing Cash & Cash Equivalent Growth (%)0.00-93.031,422.4077.06-12.36
    Total Debt/ CFO (x)--0.780.000.00-1.03

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2025
    Return on Equity (%)4.85
    Return on Capital Employed (%)22.03
    Return on Assets (%)0.12
    Interest Coverage Ratio (x)1.84
    Asset Turnover Ratio (x)-
    Price to Earnings (x)34.48
    Price to Book (x)1.67
    EV/EBITDA (x)124.94
    EBITDA Margin (%)2.39
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)3.5376.1952.3521.8212.45
    Return on Capital Employed (%)20.67126.4670.6333.044.54
    Return on Assets (%)0.091.680.470.481.24
    Interest Coverage Ratio (x)1.7014.04-98.9615.940.00
    Asset Turnover Ratio (x)0.132.610.743.85233.65
    Price to Earnings (x)48.0833.4449.0246.3033.00
    Price to Book (x)1.7025.4625.6210.104.11
    EV/EBITDA (x)134.9421.1432.6228.3935.81
    EBITDA Margin (%)4.041.341.460.330.79

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters99,45,6001.13 %0.00
    Pledge00.00 %0.00
    FII1,50,00,0001.70 %-
    Others85,70,44,53297.17 %-1.70
  • CategoryDec 2025Sep 2025Jun 2025Mar 2025
    Promoters1.131.131.131.11
    Pledge0.000.000.000.00
    FII1.700.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others97.1798.8798.8798.89

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Quarterly Results

    Apr 01, 2026

    Board Meeting

    Quarterly Results

    Mar 09, 2026

    Board Meeting

    Quarterly Results

    Feb 25, 2026

  • Announced onMeeting on
    Apr 01, 2026Mar 30, 2026
    Quarterly Results
    Mar 09, 2026Mar 09, 2026
    Quarterly Results
    Feb 25, 2026Feb 25, 2026
    Quarterly Results
    Feb 14, 2026Feb 14, 2026
    Quarterly Results
    Nov 06, 2025Nov 14, 2025
    Quarterly Results
  • No Data Available

  • Announced onEx-Date
    May 27, 2024Jul 05, 2024
    Bonus Ratio: 3 share(s) for every 1 shares held
    Jun 23, 2023Jul 28, 2023
    Bonus Ratio: 9 share(s) for every 5 shares held
  • Announced onEx-Date
    Jan 08, 2024Feb 23, 2024
    Split: Old FV5.0| New FV:1.0
    Jun 23, 2023Sep 01, 2023
    Split: Old FV10.0| New FV:5.0
  • Announced onEx-Date
    Jan 22, 2025Apr 15, 2025
    Rights ratio: 61 share for every 50 held at a price of Rs 1.0
  • Announced onMeeting on
    Nov 04, 2025Dec 09, 2025
    -
    Sep 03, 2025Sep 24, 2025
    -
    Jul 10, 2025Aug 14, 2025
    -
    Mar 27, 2025Apr 29, 2025
    -
    Mar 03, 2025Apr 02, 2025
    -

About Remedium Lifecare

Supha Pharmachem Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 25.58 Crore) operating in Consumer Durables sector.

Show More

Key Indices Listed On

-

Address

Office No.9, K Raheja Prime,Marol Industrial Estate,Mumbai, Maharashtra - 400059

Executive Leadership

MA

Mansoor Abdul Vahab

Chairman, Non Ind & Non Exe Director
AM

Adarsh Munjal

Whole Time Director
BK

Bikram Kumar Mund

Independent Director
DV

Dipesh Vinod Vaidya

Independent Director
Show More

Auditors

Taori Sandeep & Associates
Anup Kumar Jain & Co.

FAQs about Remedium Lifecare share

  • 1. What's the Remedium Lifecare share price today?
    As on 25 Jun, 2026, 03:37 PM IST Remedium Lifecare share price is down by 3.33% basis the previous closing price of Rs 0.3. Remedium Lifecare share price is Rs 0.29. Return Performance of Remedium Lifecare Shares:
    • 1 Week: Remedium Lifecare share price moved remain unchanged by 0.00%
  • 2. What's the market capitalization of Remedium Lifecare?
    Market Capitalization of Remedium Lifecare stock is Rs 25.58 Cr.
  • 3. What are the returns for Remedium Lifecare share?
    Return Performance of Remedium Lifecare Shares:
    • 1 Week: Remedium Lifecare share price moved remain unchanged by 0.00%
  • 4. What has been highest price of Remedium Lifecare share in last 52 weeks?
    Remedium Lifecare share price saw a 52 week high of Rs 1.80 and 52 week low of Rs 0.25.
  • 5. What is the PE & PB ratio of Remedium Lifecare?
    The PE ratio of Remedium Lifecare stands at 2.71, while the PB ratio is 0.27.

Top Gainers

As on 04:03 PM | 25 Jun 2026
Ather Energy
998.75
684.95 (218.28%)
Ami Organics
3,300.00
2197.20 (199.24%)
Kirloskar Oil
2,484.30
1588.15 (177.22%)
Netweb Technologies
4,943.80
3137.00 (173.62%)
Syrma SGS Technology
1,440.50
911.50 (172.31%)

Top Losers

As on 04:03 PM | 25 Jun 2026
Tata Investment
678.85
-6205.15 (-90.14%)
Angel One
335.25
-2682.35 (-88.89%)
Kotak Bank
409.00
-1717.80 (-80.77%)
CAMS
798.30
-3274.40 (-80.40%)
WABCO India
2,616.00
-10681.00 (-80.33%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.